Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
Modular Medical (NASDAQ:MODD) announced its Gold sponsorship of the inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference, scheduled for November 12-13, 2024, in Chicago. The conference, a joint initiative between the American Diabetes Association and T1D Exchange, aims to address health equity in type 1 and type 2 diabetes. The company, which recently received FDA clearance for its user-friendly and affordable patch pump MODD1, will use the conference to showcase its product and plans to improve patient access to diabetes technology.
Modular Medical (NASDAQ:MODD) ha annunciato il suo patrocinio Oro per la prima Conferenza per il Raggiungimento dell'Equità nella Pratica per il Diabete Oggi (ADEPT), prevista per il 12-13 novembre 2024 a Chicago. La conferenza, un'iniziativa congiunta dell'Associazione Americana del Diabete e del T1D Exchange, si propone di affrontare l'equità sanitaria nel diabete di tipo 1 e tipo 2. L'azienda, che ha recentemente ricevuto l'approvazione della FDA per la sua pompa a cerotto MODD1, utilizzerà l'evento per presentare il suo prodotto e i piani per migliorare l'accesso dei pazienti alla tecnologia per il diabete.
Modular Medical (NASDAQ:MODD) anunció su patrocinio de Oro para la inaugural Conferencia para Lograr la Equidad en Diabetes en la Práctica Hoy (ADEPT), programada para el 12 y 13 de noviembre de 2024 en Chicago. La conferencia, una iniciativa conjunta entre la Asociación Americana de Diabetes y T1D Exchange, tiene como objetivo abordar la equidad en la salud en la diabetes tipo 1 y tipo 2. La compañía, que recientemente recibió la aprobación de la FDA para su práctica y asequible bomba de parche MODD1, utilizará la conferencia para mostrar su producto y presentar planes para mejorar el acceso de los pacientes a la tecnología para la diabetes.
모듈러 메디컬 (NASDAQ:MODD)는 2024년 11월 12-13일 시카고에서 열릴 첫 번째 당뇨병 형평성을 위한 실천 오늘(ADEPT) 회의의 금 sponsor와 함께 한다고 발표했습니다. 이 회의는 미국당뇨병협회와 T1D Exchange의 공동 이니셔티브로, 제1형 및 제2형 당뇨병의 건강 형평성을 다루는 것을 목표로 합니다. 최근 사용하기 쉽고 저렴한 패치 펌프 MODD1에 대해 FDA 승인을 받은 이 회사는 회의를 통해 자사의 제품을 선보이고 당뇨병 기술에 대한 환자의 접근성을 개선하기 위한 계획을 발표할 예정입니다.
Modular Medical (NASDAQ:MODD) a annoncé son parrainage en or de la première Conférence sur l'Équité en Diabète dans la Pratique Aujourd'hui (ADEPT), prévue pour le 12-13 novembre 2024 à Chicago. La conférence, une initiative conjointe de l'Association Américaine du Diabète et de T1D Exchange, vise à aborder l'équité en santé dans le diabète de type 1 et de type 2. L'entreprise, qui a récemment reçu l'approbation de la FDA pour sa pompe à patch MODD1, utilisera la conférence pour présenter son produit et ses plans visant à améliorer l'accès des patients à la technologie du diabète.
Modular Medical (NASDAQ:MODD) hat seine Gold-Sponsoring für die erste Konferenz zur Erreichung von Gleichheit in der Diabetespraxis heute (ADEPT) angekündigt, die für den 12.-13. November 2024 in Chicago geplant ist. Die Konferenz, eine gemeinsame Initiative der American Diabetes Association und T1D Exchange, zielt darauf ab, die gesundheitliche Chancengleichheit bei Typ-1- und Typ-2-Diabetes anzugehen. Das Unternehmen, das kürzlich die FDA-Zulassung für seine benutzerfreundliche und kostengünstige Patch-Pumpe MODD1 erhalten hat, wird die Konferenz nutzen, um sein Produkt vorzustellen und Pläne zur Verbesserung des Zugangs der Patienten zu Diabetes-Technologie zu präsentieren.
- FDA clearance obtained for MODD1 patch pump
- Strategic positioning in diabetes equity market through conference sponsorship
- None.
SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it is a Gold sponsor of the upcoming, first annual Achieving Diabetes Equity in Practice Today (ADEPT) Conference taking place at the Chicago Marriott Downtown on November 12 and 13,2024. The ADEPT Conference, which is the result of a collaborative effort between the American Diabetes Association and the T1D Exchange, will bring together key stakeholders focused on achieving health equity in type 1 and type 2 diabetes.
"We are very pleased and proud to be a sponsor of this important new conference," said Jeb Besser, CEO of Modular Medical. "The conference mission aligns closely with our corporate vision to revolutionize patient access by enabling rapid uptake of important diabetes technology for the people with insulin-requiring diabetes who might benefit most. We look forward to meeting key stakeholders and sharing details on our debut insulin pump, the MODD1, and our plans to bring it to market," Mr. Besser added.
"We are excited to welcome Modular Medical as a Gold sponsor of this inaugural ADEPT Conference," said David Walton, CEO of the T1D Exchange. "We applaud the Company's focus on improved patient access to diabetes technology, especially so early in their product lifecycle," Mr. Walton concluded.
About Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on accesswire.com
FAQ
When is the ADEPT Conference sponsored by Modular Medical (MODD) taking place?
What product has Modular Medical (MODD) received FDA clearance for?
Who are the organizing partners of the ADEPT Conference that Modular Medical (MODD) is sponsoring?
